162 related articles for article (PubMed ID: 9974415)
1. Serum paraoxonase after myocardial infarction.
Ayub A; Mackness MI; Arrol S; Mackness B; Patel J; Durrington PN
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):330-5. PubMed ID: 9974415
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
Sentí M; Tomás M; Marrugat J; Elosua R;
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
Mackness B; Mackness MI; Arrol S; Turkie W; Julier K; Abuasha B; Miller JE; Boulton AJ; Durrington PN
Atherosclerosis; 1998 Aug; 139(2):341-9. PubMed ID: 9712341
[TBL] [Abstract][Full Text] [Related]
4. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study.
Sentí M; Tomás M; Vila J; Marrugat J; Elosua R; Sala J; Masiá R
Atherosclerosis; 2001 Jun; 156(2):443-9. PubMed ID: 11395042
[TBL] [Abstract][Full Text] [Related]
5. The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients.
Ombres D; Pannitteri G; Montali A; Candeloro A; Seccareccia F; Campagna F; Cantini R; Campa PP; Ricci G; Arca M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1611-6. PubMed ID: 9763534
[TBL] [Abstract][Full Text] [Related]
6. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients.
Tomás M; Sentí M; García-Faria F; Vila J; Torrents A; Covas M; Marrugat J
Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2113-9. PubMed ID: 10978257
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene.
Sentí M; Aubó C; Tomás M
Metabolism; 2000 May; 49(5):557-9. PubMed ID: 10831161
[TBL] [Abstract][Full Text] [Related]
8. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
[TBL] [Abstract][Full Text] [Related]
9. Serum paraoxonase activity decreases in rheumatoid arthritis.
Tanimoto N; Kumon Y; Suehiro T; Ohkubo S; Ikeda Y; Nishiya K; Hashimoto K
Life Sci; 2003 May; 72(25):2877-85. PubMed ID: 12697270
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?
Mackness B; Davies GK; Turkie W; Lee E; Roberts DH; Hill E; Roberts C; Durrington PN; Mackness MI
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1451-7. PubMed ID: 11557671
[TBL] [Abstract][Full Text] [Related]
11. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
12. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease.
MacKness B; Mackness MI; Durrington PN; Arrol S; Evans AE; McMaster D; Ferrières J; Ruidavets JB; Williams NR; Howard AN
Eur J Clin Invest; 2000 Jan; 30(1):4-10. PubMed ID: 10619995
[TBL] [Abstract][Full Text] [Related]
14. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
[TBL] [Abstract][Full Text] [Related]
15. Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes.
Inoue M; Suehiro T; Nakamura T; Ikeda Y; Kumon Y; Hashimoto K
Metabolism; 2000 Nov; 49(11):1400-5. PubMed ID: 11092501
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls.
Mackness B; Durrington PN; Boulton AJ; Hine D; Mackness MI
Eur J Clin Invest; 2002 Apr; 32(4):259-64. PubMed ID: 11952811
[TBL] [Abstract][Full Text] [Related]
17. Dietary fat modulates serum paraoxonase 1 activity in rats.
Kudchodkar BJ; Lacko AG; Dory L; Fungwe TV
J Nutr; 2000 Oct; 130(10):2427-33. PubMed ID: 11015468
[TBL] [Abstract][Full Text] [Related]
18. Serum paraoxonase (PON1) concentration in patients undergoing hemodialysis.
Suehiro T; Ikeda Y; Shiinoki T; Inoue M; Kumon Y; Itahara T; Hashimoto K
J Atheroscler Thromb; 2002; 9(3):133-8. PubMed ID: 12226554
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase Gln-Arg(192) and Leu-Met(55) gene polymorphisms and enzyme activity in a population with a low rate of coronary heart disease.
Ferré N; Tous M; Paul A; Zamora A; Vendrell JJ; Bardají A; Camps J; Richart C; Joven J
Clin Biochem; 2002 May; 35(3):197-203. PubMed ID: 12074827
[TBL] [Abstract][Full Text] [Related]
20. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
